MedPath

Comparison of immunogenicity and short term reactogencity of MMR vaccine

Not Applicable
Conditions
MMR.
Need for immunization against measles-mumps-rubella [MMR]
Registration Number
IRCT138806252471N1
Lead Sponsor
Deputy of food and drugs, Ministry of health and Medical Education
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
720
Inclusion Criteria

Healthy children
Exclusion criteria: Incomplete vaccination card, immunodeficiency disease, severe asthma and allergy

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Antibody response against Measles, Mumps and Rubella. Timepoint: Start (0), 2, 6 month after vaccination. Method of measurement: ELISA.
Secondary Outcome Measures
NameTimeMethod
Vaccines reactogencity. Timepoint: Immediately and two month after vaccination. Method of measurement: Checking by parents and physician.
© Copyright 2025. All Rights Reserved by MedPath